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ABSTRACT 
 
Objective: This study aimed to analyse individual-patient electronic health records to 
evaluate changes in antibiotic (AB) prescribing in England for different age-groups, for males 
and females, and by prescribing indications from 2014 to 2017.  
Methods: Data were analysed for 102 general practices in England that contributed data to 
the UK Clinical Practice Research Datalink (CPRD) from 2014 to 2017. Prescriptions for all 
ABs and for broad-spectrum β-lactam ABs were evaluated. Relative rate reductions (RRR) 
were estimated from a random effects Poisson model adjusting for age, gender and general 
practice. 
Results: Total AB prescribing declined from 608 prescriptions per 1,000 person years in 
2014 to 489 per 1,000 in 2017; RRR, 6.9% (95% confidence interval 6.6 to 7.1%) per year. 
Broad-spectrum β-lactam AB prescribing decreased from 221 per 1,000 in 2014 to 163 per 
1,000 in 2017; RRR 9.3% (9.0% to 9.6%) per year. Declines in AB prescribing were similar 
for men and women but the rate of decline was lower over the age of 55 years than for 
younger patients. All AB prescribing declined by 9.8% (9.6% to 10.1%) per year for 
respiratory infections, 5.7% (5.2% to 6.2%) for genito-urinary infections but by 3.8% (3.1% to 
4.5%). Overall, 38.8% of AB prescriptions were associated with codes that did not suggest 
specific clinical conditions and 15.3% of AB prescriptions had no medical codes recorded. 
Conclusion: Antibiotic prescribing has reduced and become more selective but substantial 
unnecessary AB utilisation may persist. Improving the quality of diagnostic coding for AB 
utilisation will help to support antimicrobial stewardship efforts.  
 
Key words: antibiotics; primary care; antimicrobial resistance; broad-spectrum β-lactam 
antibiotics; respiratory tract infection 
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Strengths and limitations of this study 
• The study findings are derived from analysis of electronic health records data for 
more than 100 general practices in England that continuously contributed to CPRD 
data set over the study period. 
• Comprehensive data for all antibiotic prescriptions and consultations at general 
practice surgeries were analysed. 
• Antibiotic prescriptions issued outside general practices in out-of-hours settings were 
not captured. 
• Antibiotic prescriptions may not always have been dispensed or taken by patients. 
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INTRODUCTION 
 
Antimicrobial resistance (AMR) is a growing concern world-wide.(1, 2) Many disease-
causing pathogens have now developed resistance to antimicrobial drugs. (3) The pathways 
to high rates of antibiotic resistance at population level are complex but excessive antibiotic 
utilisation in the context of medical care is often a proximal cause of antibiotic resistance (4, 
5) especially in community settings.(6-8) Consequently, there are increasing calls for more 
carefully considered use of antibiotics in healthcare settings in order to conserve the 
therapeutic potential of available antimicrobial drugs.(9) This is particularly relevant in 
primary care settings where more than 70% of all antibiotics are prescribed. (10, 11) 
Inappropriate AB prescribing is known to be widespread in primary care.(12) Based on 
international comparisons, with both low- (13) and high-(14) antibiotic prescribing being 
observed across Europe, without comparable variation in safety outcomes such as bacterial 
infections, it appears that a substantial reduction of present antibiotic prescribing in primary 
care might be safe and feasible.  
 
In order to address these concerns, aggregated data for antibiotic prescribing are now being 
used for health service management. A contractual financial incentive, known as a ‘Quality 
Premium’, has been introduced into the English NHS for meeting indicative targets for year-
on-year reductions in inappropriate AB utilisation across all indications (15). The English 
Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR)(10) 
analysed aggregated prescribing data and found that general practice antibiotic prescriptions 
decreased by 13% between 2012 and 2016. Analysis of data for individual patients offers an 
opportunity for more detailed understanding of this decreasing trend. Dolk et al.(16) 
analysed data from the THIN database from 2013 to 2015 and drew attention to limitations of 
primary care records as a data source, including the high proportion of antibiotic 
prescriptions for which no ‘clinical justification’ was recorded. The purpose of the present 
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study is to update data for antibiotic prescribing trends in English general practices from 
2014 to 2017. The analyses specifically aimed to provide estimates for the decline in 
antibiotic use separately for males and females and for people of different ages. We also 
aimed to evaluate which prescribing indications, were most associated with reduced 
prescribing. We compared changes in all antibiotic prescribing with changes in prescribing of 
broad-spectrum beta-lactam antibiotics. Finally, we aimed to compare reductions in 
prescribing of individual major classes of antibiotics to provide complementary information. 
 
METHODS 
 
Data source 
The UK Clinical Practice Research Datalink (CPRD) (17) was used as the data source for 
the study. This is a prospectively collected primary care database including data from 
approximately 7% of UK general practices. The total number of patients ever registered in 
CPRD is about 11 million, but the registered population has varied over time and by 2017 
there were approximately 2.5 million active UK patients. In the UK, more than 98% of the 
population are registered with a general practice and registrations are often maintained over 
many years. The CPRD is considered to be representative of the UK population. (17) Data 
collected into CPRD are of high quality and include all medical diagnoses recorded at 
consultations and referrals, as well as all drug prescriptions issued by general practices. (18) 
For this study we included data from CPRD general practices in England, which participated 
in the data linkage scheme, and consistently contributed data in all years from 2014 to 2017. 
During this period the total number of general practices in the UK contributing to CPRD 
declined from 491 in 2014 to 285 in 2017. The number of CPRD general practices in 
England declined from 329 to 133, while the number participating in the data linkage scheme 
declined from 257 to 102. (Supplementary Table 1). Individual participant data were included 
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from the later of 1st January 2014 or the start of the patient’s CPRD record to the earlier of 
31st December 2017 or the end of the patient’s CPRD record. Data were obtained from the 
February 2018 release of CPRD. For practices that ended CPRD data collection during 
2017, an equivalent end-of-year-date was also adopted for earlier years, because of the 
marked seasonality in antibiotic utilisation. 
 
Main measures 
For each year of study, we calculated the person-time contributed by each patient between 
1st January of the year, or start of registration if this was later, to 31st December of the year, 
or end of registration or date of death, if these were earlier. Person-time was employed as 
denominator for rates. Prescriptions for antibiotics were identified using product codes for all 
antibiotic drug classes included in section 5.1 of the British National Formulary (BNF) except 
anti-tuberculous, anti-lepromatous agents and methenamine, which were excluded.(19) The 
BNF groups antibiotic drugs into the following categories: penicillins, cephalosporins 
(including carbapenems), tetracyclines, aminoglycosides, macrolides, clindamycin, 
sulphonamides (including combinations with trimethoprim), metronidazole and tinidazole, 
quinolones, drugs for urinary tract infection (nitrofurantoin) and other antibiotic drugs. We 
analysed broad-spectrum β-lactam antibiotics as a separate group, including the British 
National Formulary category of ‘broad-spectrum penicillins’ (19) and cephalosporins. The 
category of ‘broad-spectrum penicillins’ includes ampicillin and amoxycillin and combinations 
with clavulanic acid or flucloxacillin. Carbapenems, which are only rarely used in primary 
care, were combined with cephalosporins for these analyses. Clinical indications for 
antibiotic prescription were grouped into categories based on Read medical codes recorded 
into patients’ clinical and referral records on the same date as the AB prescription including: 
‘respiratory conditions’, ‘genitourinary conditions’, ‘skin’ conditions, ‘eye’ conditions, or no 
codes recorded. (Supplementary Table 2 to 5). All other codes were grouped into a single 
category of ‘other and non-specific codes’. The most frequently used codes in this category 
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are shown in Table 1 and included ‘telephone encounter’, ‘patient reviewed’ and ‘telephone 
triage encounter’ as the most frequently used codes. Since specific coded indications for 
antibiotic therapy were infrequent in this category, it is subsequently referred to as ‘non-
specific’. We analysed the prescription sequence variable to determine whether each 
prescription was the first in a sequence or whether it was a repeat prescription; the former 
were coded as ‘acute’ prescriptions and the latter were coded as ‘repeat‘ prescriptions.  
 
Statistical analysis 
Antibiotic prescriptions for all AB and broad-spectrum β-lactam AB were enumerated by 
year. AB prescriptions of the same type on the same date were considered as a single 
event. Age was included as a continuous covariate but was also analysed in sub-groups 
from 0-4 years, then 10-year age-groups up to 85 years and over. Read codes recorded on 
the same date as an AB prescription were analysed according to indication. The primary 
indication on each date was allocated by giving priority to indications in the following 
sequence: respiratory, genitourinary, skin and eye. We estimated antibiotic prescription rates 
per 1,000 person years, and proportions of registered patients with AB prescribed in year in 
relation to age-group, gender, study year and main indication. In order to estimate annual 
changes in antibiotic prescribing, we fitted in hierarchical generalized linear Poisson models 
using the ‘hglm’ package (20) in the R program. The dependent variable was a count of 
antibiotic prescriptions (either all AB prescriptions or broad-spectrum β-lactam AB 
prescriptions). Predictors were calendar year, gender and age, including quadratic and cubic 
terms to allow for non-linear effects of age. Calendar year was included as a linear predictor 
based on inspection of descriptive data and because non-linear effects would be difficult to 
estimate over a four year period. A random effect for general practice was included because 
of the repeated observations on general practices over years. The log of person-time was 
included as offset. Relative rate reductions were estimated as one minus the adjusted 
relative rate for the linear effect of calendar year. In view of the size of the dataset, we 
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present confidence intervals rather than significance tests. Results were presented using the 
‘ggplot2’ and ‘forestplot’ packages (21) in the R program (22). 
 
Research Ethics 
The research protocol for this study was submitted to and approved by the Medicines and 
Healthcare Products Regulatory Agency (MHRA) Independent Scientific Advisory Committee 
(ISAC), Protocol 16_020. All patients’ electronic health records analysed for this study were 
fully anonymized. 
 
Patient and Public involvement 
Neither patients nor public were involved in the development and design of this study, nor 
the selection of outcome measures, nor the conduct, analysis and dissemination of the 
study.  
 
RESULTS 
 
Overall antibiotic prescriptions  
Analyses included 102 general practices that contributed data in each year from 2014 to 
2017 (Table 2). The registered population was 1.03 million in 2014 increasing to 1.07 in 
2017. There were 539,219 AB prescriptions in 2014, declining to 459,476 in 2017. The AB 
prescribing rate declined from 608 per 1,000 in 2014 to 489 per 1,000 in 2017. The 
proportion of registered patients that were prescribed antibiotics in each year declined from 
just over 1 in 4 (25.3%) in 2014 to just over 1 in 5 (21.1%) in 2017. Figure 1 (left panel) 
shows changes in the proportion of patients prescribed antibiotics by year over the study 
period. A consistent year-on-year reduction was observed in each age-group from 0 to 4 
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years to 85 years and over. Marked antibiotic prescribing variations were observed in 
relation to age, with the highest rates at the extremes of age.  
 
There were 195,750 broad-spectrum β-lactam AB prescriptions in 2014, declining to 153,423 
in 2017. The proportion of all AB prescriptions that were broad-spectrum β-lactams 
decreased from 36.3% in 2014 to 33.3% in 2017 (Table 2). Figure 1 (right panel) shows the 
change in proportion of patients prescribed broad spectrum β-lactam AB by age-group. 
While there was a year-on-year decrease in broad-spectrum β-lactam AB use in each age-
group, the absolute reduction appeared to be greater at older ages in whom broad-spectrum 
β-lactam AB use was greatest. 
 
Table 3 presents data for AB prescribing indications. Respiratory consultations accounted for 
the most frequent defined indication with 168,852 (31%) prescriptions in 2014 and 129,032 
(28%) in 2017. Genitourinary infections and skin infections accounted for 9% and 7% of AB 
prescriptions respectively with little change over years. There were 77,431 (14%) AB 
prescriptions with no associated medical codes recorded in 2014 and 73,596 (16%) in 2017. 
There were 204,395 (39%) of antibiotic prescriptions with other and non-specific codes 
recorded in 2014 and 181,018 (39%) in 2017. Overall, there were more than half (54.1%) of 
the AB prescriptions were documented without specific clinical conditions recorded. 
 
Table 4 shows the proportion of repeat prescriptions for different prescribing indications. In 
2017, 78,166 (17%) of antibiotic prescriptions were recorded as repeat prescriptions. The 
proportion of repeat prescriptions was 2% or lower for respiratory, genitourinary or eye 
conditions. For skin infections, 8% of antibiotic prescriptions were recorded as repeat 
prescriptions. There were 10% of repeat prescriptions among antibiotic prescribing episodes 
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associated with non-specific codes. Among 73,596 antibiotic prescriptions in 2017 with no 
medical codes recorded, 56,216 (76%) were recorded as repeat prescriptions. 
 
Informed by the apparent consistent annual declines in antibiotic prescribing noted in Table 
2 and Figure 1, Figure 2 presents a Forest plot of annual relative reductions in AB 
prescribing adjusted for age, gender and general practice. Estimates for all antibiotic 
prescribing are shown in blue and for broad-spectrum β-lactam AB prescribing in red. The 
annual relative reduction in all AB prescribing was 6.9% (95% confidence interval 6.6% to 
7.1%). Estimates were generally similar for males and females. For participants aged less 
than 55 years, the sub-group estimates were all greater than the overall estimate, being 
greatest at age 45 to 54 years at 9.2% (8.4% to 9.9%) per year. For participants older than 
55 years, estimates were consistently lower than the overall estimate being lowest at age 75 
to 84 years and above at 4.3% (3.4% to 5.1%) per year. Considering sub-groups of 
indications, rates of decline were greatest for respiratory indications (9.8%, 9.6% to 10.1%), 
and eye indications (11.0%, 9.9% to 12.2%). The rate of decline was smallest for AB 
prescriptions with no recorded indication (3.8%, 3.1% to 4.5%). The overall rate of decline 
was faster for broad-spectrum β-lactam AB than all AB at 9.3% (9.0% to 9.6%). Estimates 
were consistent for males and females. The greatest relative decline was observed at 45 to 
54 years (12.5%, 11.5% to 13.5%) and the lowest at 75 to 84 years (5.7%, 4.7% to 6.7%). 
The greatest decline was for skin condition indications (14.9%, 13.9% to 15.9%) and lowest 
for un-coded indications (5.5%, 4.5% to 6.4%). 
 
Changes in different classes of antibiotics 
Figure 3 presents changes over time in the utilisation of different classes of antibiotics. The 
most frequently issued antibiotics were penicillins, accounting for 56% of AB prescriptions in 
men and 44% in women in 2017; macrolides, men 14%, women 12%; tetracyclines, men 
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14%, women 12%; sulphonamide and trimethoprim combination, men 6%, women 11%. the 
latter class be more frequently used in females. Clindamycin, aminoglycosides and other 
antibiotics accounted for less than 1% of antibiotic prescriptions and are not shown. During 
the period of study, drugs for urinary tract infections (nitrofurantoin) increased as a 
proportion of all antibiotic prescriptions, in men from 2.6% in 2014 to 4.2% in 2017, and in 
women from 8.8% in 2014 to 13.7% in 2017. Tetracycline use also increased between 2014 
and 2017, in men from 12.8% to 14.5% and in women from 10.1% to 11.6%. Most other 
categories appeared to show slight declines. Both penicillin and macrolides were mainly 
prescribed for treating respiratory conditions, whereas tetracyclines was frequently issued for 
skin conditions among young patients and respiratory conditions in later life. There was a 
decline in the use of sulphonamide/trimethoprim combinations for urinary conditions while a 
notable increase of nitrofurantoin use for these conditions was observed over study years 
among all age groups but more particularly in women.  
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DISCUSSION 
 
Main findings 
The rate of antibiotic prescriptions and the proportion of patients receiving antibiotics have 
declined consistently over this four-year period. Antibiotic utilisation shows important 
patterning by age and gender, being higher in very young and very old people and higher in 
women than men. However, the present results show that a reduction in antibiotic utilisation 
is being achieved across all ages groups and in females as well as males. The gender gap 
in relation to antibiotic prescribing could be due to differences in medical care-seeking 
behaviour or specific conditions which disproportionally affect one gender (23). Among 
prescriptions associated with coded indications, respiratory conditions were the most 
frequent indication for antibiotic prescription and also showed the greatest rate of decline. 
Consistent with other recent reports,(16) we find that a substantial proportion of antibiotic 
prescriptions are not associated with specific coded clinical indications out of which a major 
share was associated with repeat prescriptions. Antibiotic prescriptions that were not 
associated with medical codes, showed the slowest rate of decline, potentially further 
identifying this category of prescriptions as representing a sub-optimal standard of clinical 
practice which might hamper the accurate estimation of drug indications. Therefore, 
enhancing the quality of clinical information recording is warranted in order to improve 
patient care, as well as the usefulness of records for research and health service 
management.  
 
More than one third of prescriptions were for β-lactam antibiotics and there was evidence of 
an important decline in antibiotic prescribing in this category consistent with previous 
evidence. (10) The relative reductions of broad-spectrum β-lactam prescriptions were 
greater than for overall antibiotic utilisation. Broad-spectrum β-lactam antibiotics may not 
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necessarily offer more effective coverage of causal pathogens than their more specific 
counterparts. The present results suggest that clinicians are gradually shifting to more 
targeted narrow-spectrum substitutions when possible. There is no universally accepted 
definition for ‘broad-spectrum’ antibiotics.(10, 19) This study analysed a separate category of 
β-lactam antibiotics that were broad-spectrum (as ‘broad-spectrum beta-lactam antibiotics’) 
to illustrate the possible difference in prescribing trends between these broad-spectrum 
antibiotics and their counterparts. For most common and uncomplicated infections, narrower 
spectrum drugs are generally recommended as first-line agents in general practices (24). 
Macrolides are generally recommended as substitutions for penicillin in the case of penicillin 
allergy, as well as for specific indications including Legionella or the eradication of 
Helicobacter pylori (HP). Nevertheless, macrolides were frequently prescribed in this and 
other studies. (25, 26). Clinical use of tetracyclines was low in children in recognition of the 
risk of deposition in growing bone and teeth (27) but the overall use of tetracyclines was 
higher at other ages. The increase of nitrofurantoin utilization was mainly due to the shift of 
guideline recommendation from trimethoprim to nitrofurantoin as empiric treatment for UTI 
(24). 
 
Strengths and limitations  
The study included more than 100 general practices in England that participated consistently 
across the four-year period of study. The CPRD includes general practices from throughout 
the UK. However, because the CPRD licence imposes limits on the size of dataset to be 
employed, we selected only CPRD general practices in England. During the period of the 
study, there was substantial attrition of the cohort of CPRD general practices as practices 
migrated from the Vision practice systems that was employed by practices contributing to the 
CPRD database. We considered that it was important to include the same general practices 
in each year of study, with more than 100 general practices included in total. However, we 
cannot be sure whether the antibiotic prescribing of general practices that left the CPRD 
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might differ from those that remained. Previous studies have demonstrated the high quality 
and completeness of primary care electronic health records in CPRD.(17) The data 
suggested that repeat antibiotic prescriptions might account for a high proportion of uncoded 
prescriptions but the prescription sequence field has not been well-validated to our 
knowledge. A concern for the present study is the possible lack of recording of out-of-hours 
prescriptions, especially those from deputising services, walk-in centres and emergency care 
settings (28). We noted that codes for telephone consultations and home visits were 
frequent among antibiotic prescriptions with non-specific coded indications, which suggests 
that some out-of-hours activity may have been captured. We also acknowledge that 
prescriptions from hospitals and specialist clinics are not included, but these are expected to 
make only a small contribution to community antibiotic utilisation. It appears unlikely that the 
large and consistent reductions in prescribing observed in this paper could be accounted for 
by shifting of prescribing to other care settings. The research analysed prescriptions issued 
and not prescriptions dispensed or consumed by patients. We were not able to determine 
whether prescribers used a delayed or deferred antibiotic prescribing strategy. For these 
reasons, we believe that actual antibiotic consumption may be slightly lower than we have 
reported. We acknowledge that there are variations in prescribing between practices,(16, 29, 
30) our analytical method allowed us to estimate overall effects, and measures of precision, 
that accommodated variation between practices. Our results show some difference from an 
earlier study(16) in terms of distribution of indications, but since different general practices, 
from different databases, were included in the two studies this may reflect variations in 
clinical practice. 
 
Comparison with other studies  
Previous analyses of primary care electronic health records have focused on antibiotic 
prescribing for respiratory infections,(31, 32) recognising that these conditions represent the 
most frequent indications for antibiotic prescription. There has been a long-term decline in 
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respiratory consultation rates in England that has contributed to reducing antibiotic utilisation 
for these conditions.(31) Some authors suggest that respiratory consultations account for 
nearly two thirds of antibiotic utilisation in primary care.(33) Our analyses are consistent with 
those of Dolk et al.(16), who found that respiratory consultations account for fewer than half 
of antibiotic prescriptions. However, a high proportion of prescriptions may be associated 
either with no medical codes or non-specific codes making interpretation difficult. There were 
further methodological differences between the Dolk et al.(16) study and our own, the former 
study relied on the THIN database with a different number of general practices participating 
in different years, as well as using code lists that may have differed in some respects. 
Consequently, minor numerical differences are to be expected. 
 
Conclusions  
The present analyses add to recent reports by providing age- and gender-adjusted estimates 
of the rate of decline in antibiotic utilisation for all antibiotics and broad-spectrum β-lactam 
antibiotics, for different prescribing indications and different population sub-groups defined 
by age and gender. The results show that the recent decline in AB utilisation is broadly 
based and has been observed in all sub-groups investigated. However, the decline in 
antibiotic utilisation has been at a faster rate for broad-spectrum β-lactam AB than all AB; 
the decline is consistent by gender but tended to be lower over age 55 years; the slowest 
rate of decline is observed for AB prescriptions with no coded indications. The results 
emphasise the utility of electronic health records for providing individual-patient data for 
surveillance of trends in antimicrobial utilisation and focusing future efforts at antimicrobial 
stewardship where these are most needed. 
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Table 1: Thirty most frequently used Read codes for ‘other and non-specific’ antibiotic 
prescribing indications. 
 
 
Read Code 
 
Read Term 
 
Number of eventsa 
 
   
9N31.00 Telephone encounter 51,504 
6A...00 Patient reviewed 32,470 
9N3A.00 Telephone triage encounter 26,900 
246..00 O/E - blood pressure reading 25,502 
242..00 O/E - pulse rate 15,918 
9Z...00 Administration NOS 9,278 
22A..00 O/E - weight 8,937 
8CB..00 Had a chat to patient 8,191 
9N1C.11 Home visit 7,813 
1371 Never smoked tobacco 6,065 
9....00 Administration 5,748 
8CAL.00 Smoking cessation advice 5,664 
8B3H.00 Medication requested 5,661 
137S.00 Ex smoker 4,642 
137P.00 Cigarette smoker 4,565 
9N3G.00 SMS text message sent to patient 3,990 
8B3S.00 Medication review 3,891 
8CA..00 Patient given advice 3,838 
246..11 O/E - BP reading 3,810 
9N4..00 Failed encounter 3,514 
661M.00 Clinical management plan agreed 3,305 
9N58.00 Emergency appointment 2,930 
1....00 History / symptoms 2,827 
212..00 Patient examined 2,691 
81H..00 Dressing of wound 2,543 
9Na..00 Consultation 2,381 
14L..00 H/O: drug allergy 2,277 
1969 Abdominal pain 2,102 
9N32.00 Third party encounter 1,948 
679..11 Advice to patient - subject 1,939 
   
amultiple codes per date were analysed
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Table 2: Numbers of antibiotic prescriptions, and antibiotic prescribing rates, by year. Figures are frequencies except where 
indicated.  
 
  
2014 
 
2015 
 
2016 
 
2017 
 
     
General practices 102 102 102 102 
Patients 1,025,539 1,058,805 1,069,513 1,071,293 
Female (%) 520,336 (50.7) 536,082 (50.6) 542,051 (50.7) 543,324 (50.7) 
Age (mean, sd, years) 39.4 (23.4) 39.5 (23.4) 39.7 (23.5) 39.9 (23.5) 
Person-time (person years) 887,580 921,735 932,544 939,620 
     
All AB prescriptions 539,219 494,185 482,917 459,476 
All AB prescribing rate (per 1,000 person years) 608 536 518 489 
Proportion of patients prescribed AB (%) 25.3 23.0 22.2 21.1 
Mean number of AB prescriptions in patients prescribed 2.08 2.03 2.03 2.03 
     
Broad-spectrum β-lactam AB prescriptions 195,750 174,353 167,056 153,423 
Broad-spectrum β-lactam AB prescribing rate (per 1,000 person years) 221 189 179 163 
Proportion of patients prescribed broad-spectrum β-lactam AB (%) 12.9 11.3 10.7 9.9 
Mean number of broad-spectrum β-lactam AB prescriptions in patients prescribed 1.48 1.46 1.45 1.45 
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Table 3: Distribution of antibiotic prescriptions by broad groups of indications. Figures are frequencies except where indicated. 
 
 2014  2015  2016  2017  Total  
 Freq. % Freq. % Freq. % Freq. % Freq. %            
AB prescriptions 539,219  494,185  482,917  459,476  1,975,797  
           
Respiratory conditions 168,852 31.3 146,025 29.5 140,263 29 129,032 28.1 584,172 29.6 
Genito-urinary conditions 47,009 8.7 44,544 9 42,453 8.8 42,401 9.2 176,407 8.9 
Skin conditions 39,579 7.3 35,299 7.1 33,640 7 32,003 7 140,521 7.1 
Eye conditions 1,953 0.4 1,622 0.3 1,586 0.3 1,426 0.3 6,587 0.3 
Non-specific codes 204,395 38 191,565 38.8 189,386 39.2 181,018 39.4 766,364 38.8 
No medical codes 77,431 14.3 75,130 15.2 75,589 15.7 73,596 16 301,746 15.3 
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Table 4: Proportion of antibiotic prescriptions that were either acute or repeat 
prescriptions in 2017. Figures are frequencies (percent of row total).  
 
 Total AB 
prescriptions 
Acute Repeat 
    
    
AB prescriptions 459,476 381,310 (83) 78,166 (17) 
    
Respiratory conditions 129,032 127,474 (99) 1,558 (1) 
Genito-urinary conditions 42,401 41,740 (98) 661 (2) 
Skin conditions 32,003 29,513 (92) 2,490 (8) 
Eye conditions 1,426 1,399 (98) 27 (2) 
Non-specific codes 181,018 163,804 (90) 17,214 (10) 
No medical codes 73,596 17,380 (24) 56,216 (76) 
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Legend for Figure 1: Proportion of patients prescribed antibiotics in year by age-group and 
calendar year. 
 
Legend for Figure 2: Forest plot showing annual relative reduction (95% confidence 
interval) in AB prescribing for all antibiotics and broad-spectrum β-lactam antibiotics 
between 2014 and 2017 for sub-groups of age and gender and different prescribing 
indications. Estimates were adjusted for age, gender and clustering by practice. 
Legend for Figure 3: Bar chart showing changes from 2014 to 2017 in the proportion of 
antibiotic prescriptions for different antibiotic classes for males and females. 
 
